Literature DB >> 2208167

Characterization of new human pancreatic cancer cell lines which propagate in a protein-free chemically defined medium.

N Yamaguchi1, Y Yamamura, K Koyama, E Ohtsuji, J Imanishi, T Ashihara.   

Abstract

Many human cancer cell lines which have been maintained in fetal bovine serum (FBS)-supplemented medium produce and secrete many substances such as transferrin, alpha 1-antitrypsin, alpha 2-macroglobulin, alkaline phosphatase, gamma-glutamyltranspeptidase, creatine kinase, carcinoembryonic antigen, alpha-fetoprotein, carbohydrate antigen 19/9, and cytokines including colony-stimulating factors and transforming growth factor, and further they may produce small amounts of unknown substances. Usually, small amounts of substances have to be concentrated as highly as possible for detection, but FBS interferes with this procedure. A protein-free culture system is an ideal method for detecting small quantities of substances which originate from cancer cells without interference by FBS. However, we were concerned that protein-free culture may interrupt the production of the substances which have been produced in FBS-supplemented medium. In this study, we investigated the productibility of 46 kinds of well-known substances in ten newly established cell lines derived from human pancreatic cancer. These cell lines were propagated in a protein-free non-FBS-supplemented medium. Of the ten cases, one cell line alone that was derived from acinal cell carcinoma propagated as a semisuspension; on the other hand, nine cell lines that were derived from ductal cell carcinoma propagated as monolayers without piling up. This method prolongs the doubling time, which is not affected by the addition of FBS. The spent media of these cell lines were collected aseptically after the removal of cell debris and concentrated by ultrafiltration using a Pericon cassette followed by lyophilization. Using 46 kinds of available antibodies, we investigated whether or not the substances which react to these antibodies could be detected in the spent media and in the cells by enzyme-linked immunosorbent assay, Western blot analysis, and immunocytochemistry. Among these cell lines, HPC-Y11 produced and secreted the most kinds of substances, and the production of those substances was lowest in HPC-Y0. In conclusion, our protein-free culture system can be available in every laboratory, since this is not only an economical method, but also an effective method for the saving of purification procedures. Moreover, this is a most suitable method for surveying unknown substances derived from cancer cell lines.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2208167

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

1.  In vitro chemosensitivity of human pancreatic cancer cell lines.

Authors:  Y Sawabe; H Yamagishi; N Yamaguchi; Y Yamamura; T Oka
Journal:  Int J Pancreatol       Date:  1996-12

2.  Establishment and characterization of SUIT-58 pancreas cancer cell line and its subline S58-SF adapted to serum-free condition derived from metastatic liver tumor.

Authors:  Nobuyasu Takahashi; Fumiyo Aoyama; Jiro Ohuchida; Naoki Sameshima; Yujiro Asada; Akira Sawaguchi
Journal:  Hum Cell       Date:  2015-07-04       Impact factor: 4.174

3.  Biosynthesis and secretion of MHC class III gene products (complement C4 and factor B) in the exocrine pancreas.

Authors:  K Sumiyoshi; A Andoh; Y Fujiyama; H Sakumoto; T Bamba
Journal:  J Gastroenterol       Date:  1997-06       Impact factor: 7.527

4.  Electrophoretic pattern changes in macrophage cell lines due to culture in protein-free medium.

Authors:  J G Bruno; E Holwitt; J L Kiel
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-06       Impact factor: 2.723

Review 5.  Neutrophil-Derived Proteases in the Microenvironment of Pancreatic Cancer -Active Players in Tumor Progression.

Authors:  Klaus Felix; Matthias M Gaida
Journal:  Int J Biol Sci       Date:  2016-01-28       Impact factor: 6.580

6.  Alpha-1 Antitrypsin Blood Levels as Indicator for the Efficacy of Cancer Treatment.

Authors:  Zeyad J El-Akawi; Aymen M Abu-Awad; Nabil A Khouri
Journal:  World J Oncol       Date:  2013-05-06

7.  In vitro reactivity and in vivo biodistribution of the monoclonal antibody A7 using human gastric carcinoma cell lines.

Authors:  N Yamaoka; T Yamaguchi; E Otsuji; M Kato; T Kotani; K Kitamura; T Takahashi
Journal:  Br J Cancer       Date:  1994-09       Impact factor: 7.640

8.  A panel of glycoproteins as candidate biomarkers for early diagnosis and treatment evaluation of B-cell acute lymphoblastic leukemia.

Authors:  Marcio de Souza Cavalcante; José Camilo Torres-Romero; Marina Duarte Pinto Lobo; Frederico Bruno Mendes Batista Moreno; Leonardo Primo Bezerra; Diego Silva Lima; Jesamar Correia Matos; Renato de Azevedo Moreira; Ana Cristina de Oliveira Monteiro-Moreira
Journal:  Biomark Res       Date:  2016-01-27

9.  K-ras and p53 alterations in genomic DNA and transcripts of human pancreatic adenocarcinoma cell lines.

Authors:  H Suwa; T Yoshimura; N Yamaguchi; K Kanehira; T Manabe; M Imamura; H Hiai; M Fukumoto
Journal:  Jpn J Cancer Res       Date:  1994-10

10.  Biodistribution of neocarzinostatin conjugated to chimeric Fab fragments of the monoclonal antibody A7 in nude mice bearing human pancreatic cancer xenografts.

Authors:  E Otsuji; T Yamaguchi; N Yamaoka; K Taniguchi; M Kato; T Kotani; K Kitamura; T Takahashi
Journal:  Jpn J Cancer Res       Date:  1994-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.